Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Chronic Lymphocytic Leukemia (CLL)
Chronic lymphocytic leukemia (CLL) is one the most common types of leukemia in adults. It's a type of cancer that starts in early forms of certain white blood cells (called lymphocytes) in the bone marrow. The cancer (leukemia) cells start in the bone marrow but then go into the blood.
In CLL, the leukemia cells often build up slowly. Many people don't have any symptoms for at least a few years. But over time, the cells can build up and spread to other parts of the body, including the lymph nodes, liver, and spleen.
Leukemia is cancer that starts in the blood-forming cells of the bone marrow. When one of these cells changes and becomes a leukemia cell, it no longer matures the way it should and grows out of control. Often, it divides to make new cells faster than normal. Leukemia cells also don't die when they should. This allows them to build up in the bone marrow, crowding out normal cells.
At some point, leukemia cells leave the bone marrow and spill into the bloodstream. This increases the number of white blood cells in the blood. Once in the blood, leukemia cells can spread to other organs, where they can prevent other cells in the body from functioning normally.
Leukemia is different from other cancers that start in organs like the lungs, colon, or breast and then spread to the bone marrow. Cancers that start somewhere else and then spread to the bone marrow are not leukemia.
Knowing the exact type of leukemia a person has helps doctors better predict their outlook and select the best treatment.
In a chronic leukemia, the leukemia cells can mature partly (and are more like normal white blood cells than the cells of acute leukemias), but they don't mature completely. These cells may look fairly normal, but they're not. They generally don't fight infection as well as normal white blood cells do.
The leukemia cells survive longer than normal cells and build up, crowding out normal cells in the bone marrow.
It can take a long time before chronic leukemias cause problems, and most people can live with them for many years. But chronic leukemias tend to be harder to cure than acute leukemias.
Leukemia is either myeloid or lymphocytic, depending on which bone marrow cells the cancer starts in.
Lymphocytic leukemias (also known as lymphoid or lymphoblastic leukemias) start in the cells that would normally become lymphocytes. Lymphomas are also cancers that start in those cells. The main difference between lymphocytic leukemias and lymphomas is that in leukemia, the cancer cells are mainly in the bone marrow and blood; in lymphoma they tend to be in lymph nodes and other tissues.
There seem to be different types of CLL, based on some of the gene changes inside the cells:
Lab tests can be done on the leukemia cells to tell which type a person has. The tests look for changes in the leukemia cells - either a deletion of part of chromosome 17 or a mutation in the TP53 gene. (The TP53 gene also is on chromosome 17, so both tests are actually looking for changes in this gene, which normally helps keep cell growth under control.) If the CLL cells have either of these changes, the leukemia tends to grow faster and might be harder to treat with certain types of medicines, so this might affect a person's treatment options.
Other gene and chromosome changes inside the CLL cells can also be important. To learn more, see How Is Chronic Lymphocytic Leukemia Staged?
The common form of CLL starts in B lymphocytes. But there are some rare types of leukemia that share some features with CLL.
In this type of leukemia, the cancer cells are a lot like normal cells called prolymphocytes. These are immature forms of either B lymphocytes (B-PLL) or T lymphocytes (T-PLL).
Both B-PLL and T-PLL tend to grow and spread faster than the usual type of CLL. They will respond to some form of treatment, but over time the leukemia tends to come back.
PLL may develop in someone who already has CLL (in which case it tends to be more aggressive), but it can also occur in people who have never had CLL.
In this rare form of chronic leukemia, the cancer cells are large and have features of either T lymphocytes or another type of lymphocyte called natural killer (NK) cells.
Most LGL leukemias are slow-growing, but a small number can grow and spread quickly. Drugs that suppress the immune system may help, but the aggressive types of leukemia can be hard to treat.
This type of leukemia gets its name from the way the cells look under the microscope -- they have fine projections on their surface that make them look "hairy."
This is a rare cancer of the lymphocytes that tends to progress slowly. The cancer cells are a type of B lymphocyte, but they're different from those seen in CLL. There are also important differences in symptoms and treatment.
Treatment for HCL is usually successful.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
Awan FT, Byrd JC. Chapter 99: Chronic lymphocytic leukemia. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.
National Cancer Institute. Chronic Lymphocytic Leukemia Treatment (PDQ®)–Health Professional Version. 2024. Accessed at https://www.cancer.gov/types/leukemia/hp/cll-treatment-pdq on June 20, 2024.
National Cancer Institute. Hairy Cell Leukemia Treatment (PDQ®)–Health Professional Version. 2024. Accessed at https://www.cancer.gov/types/leukemia/hp/hairy-cell-treatment-pdq on Juune 20, 2024.
National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2024. Accessed at https://www.nccn.org on June 20, 2024.
Last Revised: July 1, 2024
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.